• Evacetrapib and the Ferroptosis Metabolism Frontier

  2026-09-18

  The emerging link between hydrogen sulfide, homocysteine metabolism, and ferroptosis creates a sharper framework for translational experiments. This article positions Evacetrapib (LY2484595) as a research tool for disciplined pathway interrogation—not as a proven ferroptosis agent—and outlines how to connect metabolic phenotyping with mechanistic validation in non-small cell lung cancer models.

• Adamtsl3, MMP9, and Cortical Plasticity

  2026-09-17

  The reference study identifies Adamtsl3 as a cell-autonomous regulator of perineuronal-net integrity in parvalbumin-positive interneurons, acting in part through MMP9 control. Its genetic, biochemical, and plasticity experiments connect extracellular-matrix remodeling with adult cortical plasticity and provide a framework for testing gelatinase-dependent mechanisms in neuropsychiatric disease research.

• Ruthenium Red: Ca2+ Transport Inhibitor Guide

  2026-09-17

  Ruthenium Red is a Ca2+ transport inhibitor used to probe mitochondrial, erythrocyte, and sarcoplasmic-reticulum calcium movement. Product data report two binding-site constants, concentration-dependent inhibition of SR vesicle calcium binding, and complete inhibition of capsaicin-induced plasma extravasation at 5 μmol/kg in rat trachea.

• Candida krusei Forms Trigger Distinct BMEC Apoptosis

  2026-09-16

  The reference study shows that the yeast and hypha phases of Candida krusei induce bovine mammary epithelial cell apoptosis through different dominant routes: mitochondrial signaling for yeast and death ligand/receptor signaling for hyphae. Its co-culture and multiparametric design provides a useful framework for interpreting pathogen morphology, TLR responses, and JNK/ERK-associated signaling in mastitis research.

• Ethacridine Lactate Monohydrate for Research

  2026-09-16

  Ethacridine lactate monohydrate is a research-use aromatic antiseptic compound identified as 7-ethoxyacridine-3,9-diamine; 2-hydroxypropanoic acid; hydrate. Its reported solubility and storage profile support formulation screening, while its specific antiseptic mechanism and compatibility with living differentiation cultures require experimental validation.

• Magnetite–CNC Interfaces for Magnetic Hyperthermia

  2026-09-15

  This study defines how sulfated and TEMPO-oxidized cellulose nanocrystals control magnetite adsorption, interfacial bonding, magnetic behavior, and heating performance. Its quantitative structure–property relationships show why sulfated CNC composites can retain higher magnetization and intrinsic SAR, while TEMPO oxidation promotes stronger chemical interactions with Fe3O4.

• CSBTA Pharmacokinetics in MASH: Study Insights

  2026-09-15

  The reference study integrates pharmacokinetics, tissue distribution, cellular transport, and metabolic-enzyme analysis to show how HFHCD-induced MASH alters exposure to key Corydalis saxicola Bunting total alkaloids. Its findings provide a mechanistic framework for interpreting disease-dependent and repeated-dose variability when designing MASLD/MASH treatment studies.

• Reserpine (N1867): Practical Lab Workflow

  2026-09-14

  This guide provides an executable workflow for handling Reserpine (SKU N1867) in neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research when no directly matched paper evidence is available. It covers preparation, storage, controls, and troubleshooting while defining clear limits: the compound is for research use only and not for diagnostic, clinical, therapeutic, or veterinary applications.

• TRPV1+ Nerves and the Somatoautonomic Reflex

  2026-09-14

  Song et al. show that targeted stimulation of TRPV1+ peripheral afferents can suppress systemic inflammation through coordinated brainstem, endocrine, autonomic, and splenic responses. The study provides a mechanistic framework for interpreting somatic stimulation as a neural regulator of immunity, while also defining important limits for translating the findings to other inflammatory assay systems.

• Dorsomorphin (Compound C) in AMPK Assays

  2026-09-13

  Dorsomorphin (Compound C) provides reversible, cell-permeable control of AMPK while also enabling BMP/Smad pathway studies. This guide translates its dual activity into reproducible workflows for metabolism, autophagy, macrophage biology, barrier research, iron metabolism, and differentiation assays.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-12

  Brumatti, Sheridan, and Martin established a practical bacterial-expression and purification workflow for polyhistidine-tagged recombinant annexin V, followed by FITC labeling for apoptotic-cell analysis. The study’s main contribution is a reproducible route to a soluble phosphatidylserine probe suitable for flow cytometry and fluorescence microscopy, while also clarifying important assay limitations.

• PPM-18: iNOS and NF-κB Workflow Guide

  2026-09-11

  PPM-18 provides a practical way to investigate inflammation by suppressing iNOS expression through NF-κB signaling rather than directly blocking NOS enzyme activity. This guide connects dose-response, nitrite, transcriptional, protein, and nuclear-translocation assays with sepsis and bone-inflammation research use cases.

• IL-23R as a Senescence Biomarker of Aging

  2026-09-11

  This Nature Aging study identifies IL-23R as a circulating and tissue-associated marker linked to aging and cellular senescence. By comparing pharmacological senotherapeutics with genetically induced senescent-cell clearance in mice and examining human plasma, the work connects systemic biomarker changes with tissue-level responses and provides a framework for evaluating senescence-targeting interventions.

• Nocodazole at the Mitosis–Translation Interface

  2026-09-10

  Nocodazole is more than a mitotic arrest reagent. As a reversible microtubule polymerization inhibitor, it can help translational researchers connect spindle perturbation, cell-cycle timing, 4E-BP1 phosphorylation, and cancer phenotypes—provided its pleiotropic biology is separated from kinase-specific conclusions.

• EZ Cap™ Firefly Luciferase mRNA Workflow

  2026-09-10

  Build more reproducible reporter experiments with a Cap1- and poly(A)-optimized luciferase transcript designed for efficient delivery and sustained expression. This guide connects practical cell, LNP, viability, and imaging workflows with mixing-control lessons from recent formulation research.

8476 records 4/566 page Previous Next 12345 下5页 Last page